26 August 2026
Leqembi Iqlik starts U.S. treatment at home
In its Aug. 26, 2026, Q2 report, BioArctic said the FDA approved Leqembi Iqlik as weekly subcutaneous initiation therapy and that the autoinjector launched in the U.S. in August.
The full briefing is in the app.